Abstract

INTRODUCTION. Special attention is focused on the central nervous system (CNS) in AIDS because of the debilitating symptoms and unique neuropathology. Anti- viral therapy has been effective in treating many of the symptoms of AIDS. But the CNS and PNS can continue to display debilitating symptoms even when the patient is on antiviral therapy (1). Motor abnormalities and atrophy of skeletal muscle are two PNS problems that continue to resist treatment. In order to understand the disease process and to develop new therapies, animal model systems are needed (2). The recently developed HIV-1 Transgenic Rat (HIV-1 TgR) displays many neurological symptoms of AIDS (3). These symptoms include muscular wasting, weakness, difficulties in gait, and paralysis. Examination of the peripheral nerve has revealed degeneration of the axons and focal demyelination. The muscular changes may be secondary to this nerve pathology or myopathic mechanisms may be operational. The muscle in these animals was examined by histologic means. By identifying the type of degeneration it may be possible to eventual study the effect of growth factors or therapeutics. METHODS. HIV-1TGRs were constructed using transgenic protocols. The pronuclei were microinjected with an HIV-1-gag-pol-pEVd 1443 clone in which the SphI and Bal1 fragment that contained the 3’ gag region and 5’ pol region of the infectious proviral DNA pNL4.3 clone was removed. This produced a non-infectious model. Gp-120 is found in their serum. Immunocytochemistry to Gp-120, TAT and Nef localized the viral products to the lymphoid tissue. Animals were observed for neurologic abnormalities. Their clinical symptoms were recorded over time. Both nerve and muscle were removed at necropsy for histologic analysis. Tissues were prepared for light and electron microscopy. The special stains used were H&E, NADH, ATPase, lymphocyte markers, and ApopTag. Thick sections stained with Toluidine Blue. RESULTS. Depending on the muscle studied one could observe mild changes (inflammatory changes, and apoptosis to endothelial cells) to severe end stage changes (fatty replacement of muscle, phagocytosis of myocytes and necrosis). The hind limb muscle typically displayed the most marked changes. Intermediate changes include atrophic, angulated fibers (Fig.1), hypertropic fibers surrounded fat, increased connective tissue and internal nuclei (Fig. 2).

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.